Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study.
about
In Vitro Antifungal Activity of Sertraline and Synergistic Effects in Combination with Antifungal Drugs against Planktonic Forms and Biofilms of Clinical Trichosporon asahii IsolatesCNS Infections in 2016: 2016, the year of Zika virusEvolving Failures in the Delivery of Human Immunodeficiency Virus Care: Lessons From a Ugandan Meningitis Cohort 2006-2016.The CSF Immune Response in HIV-1-Associated Cryptococcal Meningitis: Macrophage Activation, Correlates of Disease Severity, and Effect of Antiretroviral TherapyCryptococcal meningitis: A neglected NTD?The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis.The Anti-helminthic Compound Mebendazole Has Multiple Antifungal Effects against Cryptococcus neoformans.Antifungal adjuvants: Preserving and extending the antifungal arsenalCryptococcal therapies and drug targets: the old, the new and the promising.Advanced HIV disease in Botswana following successful antiretroviral therapy rollout: Incidence of and temporal trends in cryptococcal meningitis.Challenges in the development of novel anticryptococcal agents.Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitis.Acridine orange fluorescent microscopy is more sensitive than India ink light microscopy in the rapid detection of cryptococcosis among CrAg positive HIV patients.Differences in Immunologic Factors Among Patients Presenting with Altered Mental Status During Cryptococcal Meningitis.Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.Troponoids Can Inhibit Growth of the Human Fungal Pathogen Cryptococcus neoformans.The antifungal pipeline: a reality check.Clinical evaluation of the antifungal effect of sertraline in the treatment of cryptococcal meningitis in HIV patients: a single Mexican center experience.Glucosamine stimulates pheromone-independent dimorphic transition in Cryptococcus neoformans by promoting Crz1 nuclear translocation.Sertraline for HIV-associated cryptococcal meningitis - Authors' reply.Cryptococcosis today: It is not all about HIV infection.New Horizons in Antifungal Therapy.Evaluation of a point-of-care immunoassay test kit 'StrongStep' for cryptococcal antigen detection.Virulence Factors as Targets for Anticryptococcal Therapy.Cryptococcal Disease in the Era of "Test and Treat": Is There Cause for Concern?The unmet clinical need of novel antifungal drugs.Repurposing drugs to fast-track therapeutic agents for the treatment of cryptococcosis.Are fluconazole or sertraline dose adjustments necessary with concomitant rifampin?The war on cryptococcosis: A Review of the antifungal arsenal.Cryptococcal meningitis.Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome.Delta-like 1 protein, vitamin D binding protein and fetuin for detection of Mycobacterium tuberculosis meningitisDetrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART InitiationPresent and Future Therapy of Infections
P2860
Q28554839-87CDF141-B28B-405A-930E-749F6D2BAF35Q28595306-AB315691-0FB9-430A-AE3C-D2F983FBC1CBQ33747751-4C784556-86BB-4F9C-BA92-952B4276D8FCQ33793447-98C09588-2BD1-434A-B4AB-C8BCE943F675Q33852819-F2F33FE1-2300-4305-BC35-75BFC4CC6A0AQ34540684-5E89B90C-E5D5-4741-AAB1-2A5B613361C6Q36344094-8FE20C25-72E7-449D-973B-E6201478C264Q37705308-B53997DE-D666-41BB-8BA4-86CAD4235594Q38779568-87B50407-716B-4F2D-B18C-EDF1C9418A96Q38785746-222EB701-31D4-4CE4-9BA4-75535983EA37Q38835037-D4EBBD11-E5F1-4AD1-87DE-C9E2BEEDE785Q38849132-E7635F6D-469F-4837-A7D7-5AF8DF558CDBQ38849478-A0890C4C-6549-4879-BBF0-FB76F64249E4Q38850833-F5340C21-CACF-4DB4-8AD5-9EB563411C09Q38851467-5FE619CB-A88D-4D8F-B3F5-B9C5750CE16FQ38975472-0D0C727E-F7B6-4FB6-AC97-1C5B6222B6E3Q39299949-FDAEA81E-20FB-4806-B942-3DFED7FD43C5Q40090559-F3C9A871-561B-481C-B25B-64442CDEC452Q41229705-CF4686AD-302A-4D5F-8ACE-6237F2B65F30Q42372326-AB269A53-D099-4635-AA1E-AB90C717EA2BQ46262999-5D38AEFD-8A61-4B90-BEB4-56EFEE8C24A3Q48149179-BC298C1F-01F0-41C0-AA6C-5CAEF7AE8ECFQ48303014-CFCCCCDF-5E02-41D7-B0FF-987B040A1FFBQ49612928-ED079C41-72EE-4449-8506-6BFA85179C0BQ49672562-B2A3ADCB-655B-4C93-8821-8F193D2E095CQ50068450-62200C23-32F6-4992-BDFA-DFE0600663D0Q53685613-F2395B2C-0CC3-4007-83E2-4C9F67ECCC2EQ53723554-E32AA8D8-DB6F-4E11-A5E7-FA388BF32B38Q54260674-3AE49148-767F-44C5-A73D-91D4AB49217BQ54368432-F2E21A7A-99E9-40D1-B3BA-3DEA66F1AEDDQ55229762-C578885F-829A-43A5-AF1C-780CB87C8A3CQ56911556-E84F2617-7764-4836-B0C4-333639745C03Q56912128-1CE43713-3F79-492D-8ADB-88195F93F076Q57177336-E6BA411F-5F53-4F37-964D-7CAEED54A8BC
P2860
Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy of adjunctive sertral ...... open-label dose-ranging study.
@en
Efficacy of adjunctive sertral ...... open-label dose-ranging study.
@nl
type
label
Efficacy of adjunctive sertral ...... open-label dose-ranging study.
@en
Efficacy of adjunctive sertral ...... open-label dose-ranging study.
@nl
prefLabel
Efficacy of adjunctive sertral ...... open-label dose-ranging study.
@en
Efficacy of adjunctive sertral ...... open-label dose-ranging study.
@nl
P2093
P2860
P50
P1476
Efficacy of adjunctive sertral ...... open-label dose-ranging study.
@en
P2093
ASTRO-CM Study Team
Abdu Musubire
Ali Alhadab
Andrew Akampurira
Darlisha A Williams
David B Meya
Henry W Nabeta
James Fisher
Kathy Huppler Hullsiek
Kirsten Nielsen
P2860
P304
P356
10.1016/S1473-3099(16)00074-8
P577
2016-03-09T00:00:00Z